Bridgewater Associates (Ray Dalio) — NBIX Trade History
Quarter-by-quarter changes in the NEUROCRINE BIOSCIENCES INC position · CUSIP 64125C109
Currently held · 3.5 YearsFirst seen: 2021 Q2
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-14 | Add | 205,677 | 57,536 | +38.8% | $34.7M | 0.14% |
| 2026 Q1 | 2026-05-15 | Reduce | 148,141 | -1,849 | -1.2% | $19.5M | 0.09% |
| 2025 Q4 | 2026-02-13 | Add | 149,990 | 126,952 | +551.1% | $21.3M | 0.08% |
| 2025 Q3 | 2025-11-13 | Add | 23,038 | 14,095 | +157.6% | $3.2M | 0.01% |
| 2025 Q2 | 2025-08-13 | Reduce | 8,943 | -78,295 | -89.7% | $1.1M | 0.01% |
| 2025 Q1 | 2025-05-14 | Reduce | 87,238 | -245,360 | -73.8% | $9.6M | 0.04% |
| 2024 Q4 | 2025-02-13 | Add | 332,598 | 197,412 | +146.0% | $45.4M | 0.21% |
| 2024 Q3 | 2024-11-13 | Add | 135,186 | 47,638 | +54.4% | $15.6M | 0.09% |
| 2024 Q2 | 2024-08-14 | Add | 87,548 | 64,397 | +278.2% | $12.1M | 0.06% |
| 2024 Q1 | 2024-05-14 | Reduce | 23,151 | -354 | -1.5% | $3.2M | 0.02% |
| 2023 Q4 | 2024-02-14 | Reduce | 23,505 | -31,490 | -57.3% | $3.1M | 0.02% |
| 2023 Q3 | 2023-11-13 | Reduce | 54,995 | -170 | -0.3% | $6.2M | 0.04% |
| 2023 Q2 | 2023-08-11 | Reduce | 55,165 | -4,045 | -6.8% | $5.2M | 0.03% |
| 2023 Q1 | 2023-05-12 | New | 59,210 | 59,210 | — | $6.0M | 0.04% |
| 2022 Q4 | 2023-02-13 | — | — | — | — | — | — |
| 2022 Q3 | 2022-11-10 | Sold out | — | -6,503 | -100.0% | — | — |
| 2022 Q2 | 2022-08-11 | Add | 6,503 | 1,483 | +29.5% | $634.0K | 0.00% |
| 2022 Q1 | 2022-05-13 | Add | 5,020 | 2,493 | +98.7% | $471.0K | 0.00% |
| 2021 Q4 | 2022-02-14 | Reduce | 2,527 | -670 | -21.0% | $215.0K | 0.00% |
| 2021 Q3 | 2021-11-12 | Reduce | 3,197 | -2,737 | -46.1% | $307.0K | 0.00% |
| 2021 Q2 | 2021-08-13 | New | 5,934 | 5,934 | — | $577.0K | 0.00% |
| 2021 Q1 | 2021-05-14 | — | — | — | — | — | — |
| 2020 Q4 | 2021-02-12 | — | — | — | — | — | — |
| 2020 Q3 | 2020-11-13 | — | — | — | — | — | — |
| 2020 Q2 | 2020-08-12 | — | — | — | — | — | — |
| 2020 Q1 | 2020-05-14 | — | — | — | — | — | — |
| 2019 Q4 | 2020-02-13 | — | — | — | — | — | — |
| 2019 Q3 | 2019-11-13 | — | — | — | — | — | — |
| 2019 Q2 | 2019-08-13 | — | — | — | — | — | — |
| 2019 Q1 | 2019-05-14 | — | — | — | — | — | — |
| 2018 Q4 | 2019-02-13 | — | — | — | — | — | — |
| 2018 Q3 | 2018-11-13 | — | — | — | — | — | — |
| 2018 Q1 | 2018-08-13 | — | — | — | — | — | — |
| 2018 Q2 | 2018-08-13 | — | — | — | — | — | — |
| 2017 Q4 | 2018-02-13 | — | — | — | — | — | — |
| 2017 Q3 | 2017-11-13 | — | — | — | — | — | — |
| 2017 Q2 | 2017-08-10 | — | — | — | — | — | — |
| 2017 Q1 | 2017-05-11 | — | — | — | — | — | — |
| 2016 Q4 | 2017-02-10 | — | — | — | — | — | — |
| 2016 Q3 | 2016-11-09 | — | — | — | — | — | — |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.